Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,270 publicly listed stocks with a combined market cap of $1.89 Trillion. Arbutus Biopharma Corp leads the sector with a market cap of $831.63 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$1.89 Trillion
Companies Listed
1,270
Largest Company
Arbutus Biopharma Corp
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 301 |
Arbutus Biopharma Corp
NASDAQ:ABUS |
$831.63 Million | $831.63 Million | USA | $4.32 | +1.41% | +1.65% | 35.71 Million |
| 302 |
Supriya Lifescience Limited
NSE:SUPRIYA |
$831.40 Million | Rs76.88 Billion | India | Rs955.20 | -2.25% | +0.76% | 21.97 Million |
| 303 |
Theravance Biopharma Inc
F:0TB |
$828.57 Million | €708.72 Million | Germany | €14.30 | +1.42% | +2.88% | 0.00 |
| 304 |
Oric Pharmaceuticals Inc
NASDAQ:ORIC |
$828.14 Million | $828.14 Million | USA | $8.40 | +1.57% | +12.00% | 41.01 Million |
| 305 |
Xencor Inc
NASDAQ:XNCR |
$827.65 Million | $827.65 Million | USA | $12.21 | -0.97% | +3.74% | 16.52 Million |
| 306 |
Kalvista Pharmaceuticals Inc
NASDAQ:KALV |
$820.37 Million | $820.37 Million | USA | $27.00 | +0.00% | +0.19% | 70.92 Million |
| 307 |
Hangzhou Biotest Biotech Co Ltd
SHG:688767 |
$817.93 Million | CN¥5.59 Billion | China | CN¥37.43 | -1.63% | +0.48% | 77.03 Million |
| 308 |
Nanjing Vazyme Biotech Co Ltd
SHG:688105 |
$807.25 Million | CN¥5.52 Billion | China | CN¥13.87 | -1.07% | +3.51% | 73.51 Million |
| 309 |
Inventiva S.A
PA:IVA |
$793.83 Million | €679.01 Million | France | €3.27 | -4.39% | -6.57% | 10.78 Million |
| 310 |
Sana Biotechnology Inc
NASDAQ:SANA |
$784.78 Million | $784.78 Million | USA | $2.85 | +6.34% | +6.34% | 109.49 Million |
| 311 |
Jiangsu Aidea Pharmaceutical Co Ltd
SHG:688488 |
$781.37 Million | CN¥5.34 Billion | China | CN¥12.69 | -1.09% | -7.78% | 145.68 Million |
| 312 |
Anhui Huaheng Biotechnology Co. Ltd. A
SHG:688639 |
$779.58 Million | CN¥5.33 Billion | China | CN¥21.30 | +0.47% | -2.61% | 124.37 Million |
| 313 |
Kura Oncology Inc
NASDAQ:KURA |
$776.42 Million | $776.42 Million | USA | $9.54 | +5.41% | +9.15% | 53.24 Million |
| 314 |
PHARMING GRP SP. ADRS
F:PHG |
$762.66 Million | €652.34 Million | Germany | €13.90 | -0.71% | -4.79% | 447.00 |
| 315 |
Annexon Inc
NASDAQ:ANNX |
$760.23 Million | $760.23 Million | USA | $4.64 | -1.49% | -12.29% | 62.16 Million |
| 316 |
Shenzhen Weiguang Biological Products Co Ltd
SHE:002880 |
$753.37 Million | CN¥5.15 Billion | China | CN¥22.70 | +1.75% | -4.06% | 30.39 Million |
| 317 |
Evommune, Inc.
NYSE:EVMN |
$750.62 Million | $750.62 Million | USA | $20.84 | +5.09% | +4.62% | 9.91 Million |
| 318 |
Alto Neuroscience, Inc.
NYSE:ANRO |
$742.07 Million | $742.07 Million | USA | $21.17 | -1.40% | +15.94% | 8.00 Million |
| 319 |
Oneness Biotech Co Ltd
TWO:4743 |
$740.84 Million | NT$23.51 Billion | Taiwan | NT$49.15 | +1.65% | -2.48% | 62.55 Million |
| 320 |
Replimune Group Inc
NASDAQ:REPL |
$739.85 Million | $739.85 Million | USA | $8.96 | +0.90% | -5.39% | 176.75 Million |
| 321 |
XOMA Royalty Corporation
NASDAQ:XOMA |
$738.97 Million | $738.97 Million | USA | $41.95 | +0.38% | -0.33% | 2.51 Million |
| 322 |
GH RESEARCH PLC DL-025
F:1KA |
$737.24 Million | €630.60 Million | Germany | €18.00 | +2.86% | -8.16% | 750.00 |
| 323 |
Geron Corporation
NASDAQ:GERN |
$724.92 Million | $724.92 Million | USA | $1.15 | +0.00% | -1.71% | 309.95 Million |
| 324 |
Maravai Lifesciences Holdings Inc
NASDAQ:MRVI |
$719.31 Million | $719.31 Million | USA | $4.96 | -0.40% | -1.20% | 62.50 Million |
| 325 |
Astria Therapeutics Inc
NASDAQ:ATXS |
$718.13 Million | $718.13 Million | USA | $5873.65 | +10.87% | +47002.25% | 16.63 Million |
| 326 |
Vor Biopharma Inc
NASDAQ:VOR |
$704.42 Million | $704.42 Million | USA | $14.07 | -2.02% | +6.91% | 20.01 Million |
| 327 |
Beijing Konruns Pharmaceutical Co Ltd
SHG:603590 |
$692.93 Million | CN¥4.74 Billion | China | CN¥29.78 | -0.50% | -2.17% | 94.25 Million |
| 328 |
PharmaResources (Shanghai) Co. Ltd. A
SHE:301230 |
$691.83 Million | CN¥4.73 Billion | China | CN¥33.87 | -1.71% | +2.08% | 129.39 Million |
| 329 |
Basilea Pharmaceutica AG
SW:BSLN |
$686.09 Million | CHF542.68 Million | Switzerland | CHF49.80 | -0.10% | +0.20% | 613.65K |
| 330 |
Shouyao Holdings (Beijing) Co. Ltd. A
SHG:688197 |
$685.51 Million | CN¥4.68 Billion | China | CN¥31.50 | -4.52% | -5.03% | 40.95 Million |
| 331 |
Omeros Corporation
NASDAQ:OMER |
$675.26 Million | $675.26 Million | USA | $9.33 | +6.75% | -4.70% | 50.13 Million |
| 332 |
Wuhan Hvsen Biotechnology Co Ltd
SHE:300871 |
$674.70 Million | CN¥4.61 Billion | China | CN¥22.85 | +2.84% | +12.01% | 136.94 Million |
| 333 |
Oculis Holding AG Ordinary shares
NASDAQ:OCS |
$673.20 Million | $673.20 Million | USA | $11.61 | +4.69% | +3.57% | 26.14 Million |
| 334 |
Aura Biosciences Inc
NASDAQ:AURA |
$666.84 Million | $666.84 Million | USA | $6.45 | +0.62% | -2.71% | 12.32 Million |
| 335 |
Wecome Pharmaceutical Co Ltd
SHE:300878 |
$666.77 Million | CN¥4.56 Billion | China | CN¥31.47 | +4.62% | +9.31% | 109.26 Million |
| 336 |
Adlai Nortye Ltd. American Depositary Shares
NASDAQ:ANL |
$665.46 Million | $665.46 Million | USA | $11.33 | +9.79% | +13.87% | 3.21 Million |
| 337 |
CytomX Therapeutics Inc
NASDAQ:CTMX |
$661.82 Million | $661.82 Million | USA | $3.04 | +1.00% | +1.33% | 77.93 Million |
| 338 |
ABBISKO CAYMAN DL-00001
F:8ZD |
$653.62 Million | €559.08 Million | Germany | €1.00 | +0.51% | +1.02% | 0.00 |
| 339 |
R&G PharmaStudies Co. Ltd. A
SHE:301333 |
$650.96 Million | CN¥4.45 Billion | China | CN¥46.06 | +0.24% | -0.92% | 35.29 Million |
| 340 |
Solid Biosciences LLC
NASDAQ:SLDB |
$646.81 Million | $646.81 Million | USA | $7.36 | +3.08% | +9.85% | 30.11 Million |
| 341 |
Sunmax Biotechnology Co Ltd
TWO:4728 |
$643.46 Million | NT$20.42 Billion | Taiwan | NT$375.00 | -0.53% | -1.06% | 280.12K |
| 342 |
Sinovac Biotech Ltd
NASDAQ:SVA |
$642.44 Million | $642.44 Million | USA | $6.47 | +0.00% | +0.00% | 0.00 |
| 343 |
Jiangsu Bioperfectus Technologies Co Ltd
SHG:688399 |
$633.04 Million | CN¥4.33 Billion | China | CN¥51.58 | -0.62% | +6.84% | 34.95 Million |
| 344 |
EirGenix
TWO:6589 |
$632.48 Million | NT$20.08 Billion | Taiwan | NT$66.40 | +0.45% | +7.27% | 14.47 Million |
| 345 |
CHA Biotech Co. Ltd
KQ:085660 |
$631.36 Million | ₩931.64 Billion | Korea | ₩12190.00 | +2.61% | -0.97% | 10.45 Million |
| 346 |
Climb Bio Inc
NASDAQ:CLYM |
$624.74 Million | $624.74 Million | USA | $11.49 | +0.44% | +8.91% | 24.55 Million |
| 347 |
Hyundai Bioscience Co. Ltd
KQ:048410 |
$620.25 Million | ₩915.25 Billion | Korea | ₩9530.00 | +6.96% | -6.20% | 74.08 Million |
| 348 |
Alpha Tau Medical Ltd
NASDAQ:DRTS |
$614.75 Million | $614.75 Million | USA | $9.67 | -1.83% | +3.42% | 24.87 Million |
| 349 |
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued
NASDAQ:TRAXV |
$613.49 Million | $613.49 Million | USA | $17.66 | +3.55% | -3.37% | 11.17 Million |
| 350 |
Qurient Co. Ltd
KQ:115180 |
$612.26 Million | ₩903.46 Billion | Korea | ₩25900.00 | +1.97% | -1.71% | 3.98 Million |
| 351 |
SpyGlass Pharma, Inc.
NASDAQ:SGP |
$608.15 Million | $608.15 Million | USA | $18.94 | +2.71% | +0.85% | 1.45 Million |
| 352 |
Beijing Scitop Bio Tech Co Ltd
SHE:300858 |
$601.11 Million | CN¥4.11 Billion | China | CN¥15.59 | +0.84% | +0.06% | 168.62 Million |
| 353 |
CorMedix Inc
NASDAQ:CRMD |
$600.87 Million | $600.87 Million | USA | $8.59 | -1.72% | +2.75% | 34.30 Million |
| 354 |
Relmada Therapeutics Inc
NASDAQ:RLMD |
$599.97 Million | $599.97 Million | USA | $6.37 | -4.21% | +7.06% | 28.37 Million |
| 355 |
Candel Therapeutics Inc
NASDAQ:CADL |
$597.89 Million | $597.89 Million | USA | $8.56 | +0.00% | +0.59% | 48.13 Million |
| 356 |
Lifecome Biochemistry Co Ltd
SHE:002868 |
$597.44 Million | CN¥4.08 Billion | China | CN¥26.27 | -0.08% | -3.70% | 69.88 Million |
| 357 |
Pharmicell
KO:005690 |
$596.95 Million | ₩880.86 Billion | Korea | ₩14680.00 | -0.07% | +10.13% | 19.88 Million |
| 358 |
Clarity Pharmaceuticals Ltd
AU:CU6 |
$590.01 Million | AU$833.86 Million | Australia | AU$2.24 | +4.19% | -3.03% | 50.54 Million |
| 359 |
BridgeBio Oncology Therapeutics, Inc.
NASDAQ:BBOT |
$581.58 Million | $581.58 Million | USA | $7.73 | -0.26% | -1.02% | 8.42 Million |
| 360 |
Bright Minds Biosciences Inc
NASDAQ:DRUG |
$580.58 Million | $580.58 Million | USA | $59.17 | -2.92% | -14.25% | 10.17 Million |
| 361 |
Assure Tech Hangzhou Co Ltd
SHG:688075 |
$577.41 Million | CN¥3.95 Billion | China | CN¥31.05 | -1.43% | -5.62% | 11.17 Million |
| 362 |
SHANGHAI JUNSHI BIO YC1
F:8SJ |
$575.15 Million | €491.96 Million | Germany | €1.89 | +4.42% | -1.56% | 0.00 |
| 363 |
Achieve Life Sciences Inc
NASDAQ:ACHV |
$572.84 Million | $572.84 Million | USA | $5.60 | +1.45% | +9.16% | 34.28 Million |
| 364 |
ChemPartner PharmaTech Co Ltd
SHE:300149 |
$569.10 Million | CN¥3.89 Billion | China | CN¥7.81 | -0.89% | -3.82% | 250.77 Million |
| 365 |
Gyre Therapeutics Inc.
NASDAQ:GYRE |
$568.59 Million | $568.59 Million | USA | $5.86 | -1.18% | -6.84% | 2.29 Million |
| 366 |
Regulus Therapeutics Inc
NASDAQ:RGLS |
$564.95 Million | $564.95 Million | USA | $8.16 | +0.25% | +0.00% | 33.90 Million |
| 367 |
BIOCYTOGEN PHARMA. H YC1
F:I54 |
$564.82 Million | €483.12 Million | Germany | €4.50 | +8.70% | -1.32% | 0.00 |
| 368 |
First Tracks Biotherapeutics
NASDAQ:TRAX |
$557.23 Million | $557.23 Million | USA | $17.88 | +1.36% | +7.71% | 11.30 Million |
| 369 |
Tectonic Therapeutic, Inc.
NASDAQ:TECX |
$547.21 Million | $547.21 Million | USA | $29.39 | -2.94% | +1.34% | 4.39 Million |
| 370 |
Beijing Bohui Innovation Technology Co Ltd
SHE:300318 |
$546.29 Million | CN¥3.73 Billion | China | CN¥4.57 | -1.51% | -5.38% | 161.33 Million |
| 371 |
MiMedx Group Inc
NASDAQ:MDXG |
$545.02 Million | $545.02 Million | USA | $3.68 | +2.22% | -1.60% | 30.07 Million |
| 372 |
Sage Therapeutics Inc
NASDAQ:SAGE |
$544.94 Million | $544.94 Million | USA | $8.68 | +0.00% | -1.03% | 85.42 Million |
| 373 |
Baolingbao Biology Co Ltd
SHE:002286 |
$526.82 Million | CN¥3.60 Billion | China | CN¥9.46 | +1.72% | +8.11% | 219.97 Million |
| 374 |
Prime Medicine, Inc. Common Stock
NASDAQ:PRME |
$523.79 Million | $523.79 Million | USA | $2.90 | +4.50% | -5.23% | 67.03 Million |
| 375 |
Zevra Therapeutics Inc.
NASDAQ:ZVRA |
$516.25 Million | $516.25 Million | USA | $12.55 | -0.79% | +18.28% | 49.56 Million |
| 376 |
Hefei Lifeon Pharmaceutical Co Ltd
SHE:003020 |
$514.29 Million | CN¥3.51 Billion | China | CN¥15.40 | -0.77% | -3.27% | 44.83 Million |
| 377 |
Pulike Biological Engineering
SHG:603566 |
$513.99 Million | CN¥3.51 Billion | China | CN¥10.15 | -3.06% | -2.68% | 67.72 Million |
| 378 |
PYC Therapeutics Ltd
AU:PYC |
$513.46 Million | AU$725.67 Million | Australia | AU$1.22 | -0.41% | -4.33% | 80.50 Million |
| 379 |
OPTHEA LTD (SP.ADR/8)
F:UKJ2 |
$512.99 Million | €438.79 Million | Germany | €3.00 | +0.00% | +0.00% | 0.00 |
| 380 |
Shanghai Shen Lian Biomedical Corp
SHG:688098 |
$512.57 Million | CN¥3.50 Billion | China | CN¥8.53 | +2.28% | +13.28% | 62.50 Million |
| 381 |
Eikon Therapeutics, Inc. Common Stock
NASDAQ:EIKN |
$505.11 Million | $505.11 Million | USA | $9.33 | +6.63% | +4.13% | 7.73 Million |
| 382 |
Cabaletta Bio Inc
NASDAQ:CABA |
$490.79 Million | $490.79 Million | USA | $3.01 | +0.00% | -7.38% | 82.05 Million |
| 383 |
AgomAb Therapeutics NV American Depositary Shares
NASDAQ:AGMB |
$488.54 Million | $488.54 Million | USA | $10.00 | +4.06% | +0.81% | 1.95 Million |
| 384 |
Hinova Pharmaceuticals Inc. A
SHG:688302 |
$484.37 Million | CN¥3.31 Billion | China | CN¥33.43 | -2.45% | -11.35% | 29.30 Million |
| 385 |
Arvinas Inc
NASDAQ:ARVN |
$483.24 Million | $483.24 Million | USA | $7.49 | -1.19% | +0.94% | 20.15 Million |
| 386 |
Rigel Pharmaceuticals Inc
NASDAQ:RIGL |
$481.79 Million | $481.79 Million | USA | $33.42 | +1.74% | +11.66% | 9.51 Million |
| 387 |
Achieve Life Sciences Inc
F:SP4P |
$480.44 Million | €410.95 Million | Germany | €4.68 | -0.85% | +9.86% | 3.20K |
| 388 |
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
$479.09 Million | CN¥3.27 Billion | China | CN¥3.18 | +1.27% | -9.14% | 2.67 Billion |
| 389 |
Kyverna Therapeutics, Inc. Common Stock
NASDAQ:KYTX |
$478.46 Million | $478.46 Million | USA | $8.15 | +1.18% | +9.10% | 19.97 Million |
| 390 |
TaiMed Biologics
TWO:4147 |
$478.46 Million | NT$15.19 Billion | Taiwan | NT$56.10 | -2.09% | +1.26% | 48.26 Million |
| 391 |
Guangzhou Boji Medical and Biotechnological Co Ltd
SHE:300404 |
$475.29 Million | CN¥3.25 Billion | China | CN¥8.42 | +0.60% | -7.37% | 259.13 Million |
| 392 |
Medigen Vaccine Biologics
TWO:6547 |
$474.89 Million | NT$15.07 Billion | Taiwan | NT$45.85 | -0.33% | -5.85% | 52.18 Million |
| 393 |
4D Molecular Therapeutics Inc
NASDAQ:FDMT |
$470.69 Million | $470.69 Million | USA | $9.22 | +4.42% | +6.71% | 17.93 Million |
| 394 |
Qingdao Vland Biotech Co Ltd
SHG:603739 |
$463.57 Million | CN¥3.17 Billion | China | CN¥12.52 | -0.40% | -1.18% | 102.69 Million |
| 395 |
Immix Biopharma Inc
NASDAQ:IMMX |
$460.86 Million | $460.86 Million | USA | $8.47 | +0.24% | +6.81% | 32.98 Million |
| 396 |
I-Mab
NASDAQ:IMAB |
$456.45 Million | $456.45 Million | USA | $3.96 | -1.74% | +0.25% | 11.39 Million |
| 397 |
Zhejiang Shouxiangu Pharm Co
SHG:603896 |
$454.87 Million | CN¥3.11 Billion | China | CN¥15.68 | +0.45% | -2.00% | 47.88 Million |
| 398 |
Apellis Pharmaceuticals Inc
NASDAQ:APLS |
$451.98 Million | $451.98 Million | USA | $3.53 | -1.33% | +5.47% | 98.21 Million |
| 399 |
Iteos Therapeutics Inc
NASDAQ:ITOS |
$448.68 Million | $448.68 Million | USA | $10.15 | +0.00% | -0.49% | 35.55 Million |
| 400 |
Assembly Biosciences Inc
NASDAQ:ASMB |
$446.98 Million | $446.98 Million | USA | $23.34 | +1.66% | +1.92% | 4.57 Million |
| 401 |
Ginkgo Bioworks Holdings
NYSE:DNA |
$439.16 Million | $439.16 Million | USA | $8.23 | +4.31% | +0.12% | 28.03 Million |
| 402 |
Prothena Corporation plc
NASDAQ:PRTA |
$438.71 Million | $438.71 Million | USA | $8.15 | -1.21% | -7.28% | 12.79 Million |
| 403 |
VALNEVA SE SP.ADS/2
F:AYJ0 |
$438.08 Million | €374.72 Million | Germany | €4.56 | +2.24% | -5.79% | 0.00 |
| 404 |
Valneva SE
PA:VLA |
$433.53 Million | €370.82 Million | France | €2.29 | +0.26% | -2.22% | 17.60 Million |
| 405 |
Design Therapeutics Inc
NASDAQ:DSGN |
$430.65 Million | $430.65 Million | USA | $11.14 | +1.55% | +4.60% | 28.83 Million |
| 406 |
Genfit S.A.
PA:GNFT |
$424.82 Million | €363.37 Million | France | €9.69 | +4.64% | +10.49% | 5.99 Million |
| 407 |
Guanhao Biotech Co Ltd
SHE:300238 |
$422.93 Million | CN¥2.89 Billion | China | CN¥10.90 | -0.82% | -4.80% | 103.07 Million |
| 408 |
Benitec Biopharma Ltd ADR
NASDAQ:BNTC |
$420.65 Million | $420.65 Million | USA | $12.70 | -2.01% | -6.62% | 3.18 Million |
| 409 |
Neurogene Inc
NASDAQ:NGNE |
$418.59 Million | $418.59 Million | USA | $29.86 | +2.61% | +12.72% | 3.34 Million |
| 410 |
Guangdong VTR Bio-Tech Co Ltd
SHE:300381 |
$417.49 Million | CN¥2.85 Billion | China | CN¥5.81 | +0.00% | -5.53% | 246.35 Million |
| 411 |
PureTech Health PLC
NASDAQ:PRTC |
$417.22 Million | $417.22 Million | USA | $17.31 | +2.64% | +2.49% | 148.71K |
| 412 |
Contineum Therapeutics, Inc. Class A Common Stock
NASDAQ:CTNM |
$416.25 Million | $416.25 Million | USA | $12.72 | +7.07% | +10.70% | 4.30 Million |
| 413 |
Beijing Kawin Technology Share-holding Co Ltd
SHG:688687 |
$415.24 Million | CN¥2.84 Billion | China | CN¥16.60 | +1.59% | -0.12% | 51.63 Million |
| 414 |
Century Therapeutics Inc
NASDAQ:IPSC |
$413.01 Million | $413.01 Million | USA | $2.30 | +2.22% | +7.98% | 21.87 Million |
| 415 |
Ocugen Inc
NASDAQ:OCGN |
$413.00 Million | $413.00 Million | USA | $1.22 | +0.83% | -4.69% | 123.27 Million |
| 416 |
AbClon Inc
KQ:174900 |
$410.81 Million | ₩606.20 Billion | Korea | ₩31750.00 | +6.54% | -5.22% | 7.84 Million |
| 417 |
Zota Health Care LImited
NSE:ZOTA |
$408.96 Million | Rs37.82 Billion | India | Rs1246.70 | +1.75% | -1.03% | 1.26 Million |
| 418 |
C4 Therapeutics Inc
NASDAQ:CCCC |
$404.68 Million | $404.68 Million | USA | $3.82 | -2.05% | -0.78% | 67.94 Million |
| 419 |
Allogene Therapeutics Inc
NASDAQ:ALLO |
$404.51 Million | $404.51 Million | USA | $1.94 | +2.11% | +3.19% | 178.57 Million |
| 420 |
Autolus Therapeutics Ltd
NASDAQ:AUTL |
$399.21 Million | $399.21 Million | USA | $1.50 | -3.85% | -1.96% | 39.20 Million |
| 421 |
Medy-Tox Inc
KQ:086900 |
$397.24 Million | ₩586.17 Billion | Korea | ₩89100.00 | +4.82% | +5.19% | 2.02 Million |
| 422 |
Monopar Therapeutics Inc
NASDAQ:MNPR |
$395.88 Million | $395.88 Million | USA | $61.47 | +2.84% | +3.35% | 4.10 Million |
| 423 |
Sagimet Biosciences Inc. Series A Common Stock
NASDAQ:SGMT |
$395.86 Million | $395.86 Million | USA | $6.47 | -0.15% | -4.29% | 17.65 Million |
| 424 |
Nanhua Bio Medicine Co Ltd
SHE:000504 |
$393.59 Million | CN¥2.69 Billion | China | CN¥8.15 | -3.89% | -9.14% | 114.13 Million |
| 425 |
Y mAbs Therapeutics
NASDAQ:YMAB |
$391.22 Million | $391.22 Million | USA | $8.61 | +0.23% | +0.35% | 21.23 Million |
| 426 |
Ovid Therapeutics Inc
NASDAQ:OVID |
$391.06 Million | $391.06 Million | USA | $2.26 | -1.74% | -5.83% | 40.20 Million |
| 427 |
Yantai Zhenghai Bio-Tech Co Ltd
SHE:300653 |
$390.09 Million | CN¥2.67 Billion | China | CN¥14.81 | +0.07% | -2.24% | 39.89 Million |
| 428 |
SHANDONG BOAN BIOTECH.H 1
F:UJ9 |
$385.61 Million | €329.84 Million | Germany | €0.53 | -1.85% | -5.36% | 0.00 |
| 429 |
X4 Pharmaceuticals Inc
NASDAQ:XFOR |
$384.82 Million | $384.82 Million | USA | $4.08 | +2.00% | +6.53% | 9.30 Million |
| 430 |
Vigil Neuroscience Inc
NASDAQ:VIGL |
$375.71 Million | $375.71 Million | USA | $8.05 | +0.00% | -0.12% | 23.19 Million |
| 431 |
Larimar Therapeutics Inc
NASDAQ:LRMR |
$372.94 Million | $372.94 Million | USA | $3.59 | +3.46% | +13.25% | 45.68 Million |
| 432 |
Checkpoint Therapeutics Inc
NASDAQ:CKPT |
$367.72 Million | $367.72 Million | USA | $4.26 | +0.00% | +0.00% | 8.67 Million |
| 433 |
Shenzhen Bioeasy Biotechnology Co. Ltd.
SHE:300942 |
$367.51 Million | CN¥2.51 Billion | China | CN¥6.20 | -2.97% | -4.02% | 124.56 Million |
| 434 |
Compass Therapeutics Inc.
NASDAQ:CMPX |
$362.84 Million | $362.84 Million | USA | $2.04 | +0.49% | +0.00% | 105.01 Million |
| 435 |
Shanghai Model Organisms Center Inc
SHG:688265 |
$362.79 Million | CN¥2.48 Billion | China | CN¥31.80 | -0.72% | -4.56% | 11.54 Million |
| 436 |
Eupraxia Pharmaceuticals Inc. Common Stock
NASDAQ:EPRX |
$362.35 Million | $362.35 Million | USA | $6.22 | +2.98% | +4.54% | 6.67 Million |
| 437 |
Autolus Therapeutics plc
F:6A3A |
$361.95 Million | €309.60 Million | Germany | €1.33 | +4.72% | -2.92% | 0.00 |
| 438 |
Puma Biotechnology Inc
NASDAQ:PBYI |
$359.70 Million | $359.70 Million | USA | $7.07 | -3.55% | +0.57% | 4.84 Million |
| 439 |
Hansa Biopharma AB
ST:HNSA |
$356.95 Million | Skr3.32 Billion | Sweden | Skr33.26 | -3.54% | +7.85% | 12.14 Million |
| 440 |
Aclaris Therapeutics Inc
NASDAQ:ACRS |
$353.21 Million | $353.21 Million | USA | $4.36 | +0.93% | +0.00% | 29.33 Million |
| 441 |
Atea Pharmaceuticals Inc
NASDAQ:AVIR |
$348.12 Million | $348.12 Million | USA | $4.35 | -3.12% | +2.35% | 7.82 Million |
| 442 |
Vanda Pharmaceuticals Inc
NASDAQ:VNDA |
$347.56 Million | $347.56 Million | USA | $5.88 | +0.17% | -2.49% | 23.09 Million |
| 443 |
Formycon AG
XETRA:FYB |
$336.85 Million | €288.12 Million | Germany | €20.00 | -2.68% | -3.15% | 252.17K |
| 444 |
Tanvex BioPharma Inc
TW:6541 |
$335.19 Million | NT$10.64 Billion | Taiwan | NT$40.15 | +1.77% | -4.18% | 11.04 Million |
| 445 |
Green Cross
KO:005250 |
$334.05 Million | ₩492.93 Billion | Korea | ₩10970.00 | +2.43% | +5.08% | 18.99 Million |
| 446 |
Suzhou Fushilai Pharmaceutical Co. Ltd.
SHE:301258 |
$333.88 Million | CN¥2.28 Billion | China | CN¥24.89 | -0.56% | -2.85% | 21.84 Million |
| 447 |
Vicore Pharma Holding AB (publ)
ST:VICO |
$332.05 Million | Skr3.09 Billion | Sweden | Skr10.96 | +3.59% | +0.00% | 16.81 Million |
| 448 |
Altimmune Inc
NASDAQ:ALT |
$330.61 Million | $330.61 Million | USA | $2.64 | +1.15% | -2.58% | 66.58 Million |
| 449 |
Clinuvel Pharmaceuticals Ltd
AU:CUV |
$330.05 Million | AU$466.46 Million | Australia | AU$9.25 | +3.24% | +3.58% | 1.88 Million |
| 450 |
Enanta Pharmaceuticals Inc
NASDAQ:ENTA |
$330.04 Million | $330.04 Million | USA | $11.44 | -3.87% | +1.42% | 5.02 Million |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries